Sign in

CIK 0001005286

  • Accelerated filer
  • Smaller reporting company

LIFECORE BIOMEDICAL, INC. \DE\

Sign in to watch
Ticker
LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
May 25
Incorporated
DE
Entity type
Operating
EIN
943025618
Phone
+1 952-368-4300
Business address
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Former names
LANDEC CORP \CA\
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 8,303 shares (grant or award)
  6. 4 Grant or award Director acquired 8,303 shares (grant or award)
  7. 4 Grant or award Director acquired 8,303 shares (grant or award)
  8. 4 Grant or award Director acquired 8,303 shares (grant or award)
  9. 4 Grant or award Director acquired 8,303 shares (grant or award)
  10. 4 Grant or award Director acquired 8,303 shares (grant or award)
  11. 4 Grant or award Director acquired 8,303 shares (grant or award)
  12. 4 Open-market buy Director bought 10,000 shares at $11.26 ($112,600)
  13. 4 Open-market buy Senior VP of Supply Chain bought 5,045 shares at $9.99 ($50,400)
  14. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $11.05 ($22,100)
  15. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $11.08 ($22,160)
  16. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.98 ($21,960)
  17. 4 Open-market buy Chief Executive Officer bought 9,000 shares at $10.61 ($95,490)
  18. 4 Open-market buy Vice President bought 10,000 shares at $10.62 ($106,200)
  19. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.64 ($21,280)
  20. 4/A Open-market buy 10% owner bought 240,587 shares at an average $10.02 ($2,410,360)

Page 8 of 47 · 936 filings